A NEW blood test could detect Alzheimer’s disease in its early stages, years before symptoms begin to show. Tests that ...

IGC Pharma, Inc. ("IGC Pharma" or the "Company") today announced data that reinforces the therapeutic potential of IGC-AD1 as a disease-modifying treatment for Alzheimer's disease. The data highlights ...

Two new papers by a team of researchers demonstrate that evaluating microRNAs in blood can be used not only to diagnose mild cognitive impairment (MCI) but also, critically, to predict the conversion ...

Researchers published a study showing that several measurements of the brain, including blood flow and the brain's ability to compensate for the lack of it, are better predictors of mild cognitive ...

Amyloid-beta and tau proteins have long been associated with Alzheimer's disease. The pathological buildup of these proteins ...

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and ...